Ibulocydine structure
|
Common Name | Ibulocydine | ||
---|---|---|---|---|
CAS Number | 1314096-68-8 | Molecular Weight | 458.264 | |
Density | 2.0±0.1 g/cm3 | Boiling Point | 567.1±60.0 °C at 760 mmHg | |
Molecular Formula | C16H20BrN5O6 | Melting Point | N/A | |
MSDS | N/A | Flash Point | 296.8±32.9 °C |
Use of IbulocydineIbulocydine is the prodrug of CDK inhibitor BMK-Y101, inhibits CDK7 and CDK9 with IC50 of 530 nM and 85 nM in kinase assays, respectively. |
Name | 4-Amino-6-bromo-1-(5-O-isobutyryl-β-L-xylofuranosyl)-1H-pyrrolo[2,3-d]pyrimidine-5-carboxamide |
---|---|
Synonym | More Synonyms |
Density | 2.0±0.1 g/cm3 |
---|---|
Boiling Point | 567.1±60.0 °C at 760 mmHg |
Molecular Formula | C16H20BrN5O6 |
Molecular Weight | 458.264 |
Flash Point | 296.8±32.9 °C |
Exact Mass | 457.059692 |
LogP | -1.48 |
Vapour Pressure | 0.0±3.5 mmHg at 25°C |
Index of Refraction | 1.768 |
1H-Pyrrolo[2,3-d]pyrimidine-5-carboxamide, 4-amino-6-bromo-1-[5-O-(2-methyl-1-oxopropyl)-β-L-xylofuranosyl]- |
4-Amino-6-bromo-1-(5-O-isobutyryl-β-L-xylofuranosyl)-1H-pyrrolo[2,3-d]pyrimidine-5-carboxamide |
Ibulocydine |